Supplemental Guarantor and Non-Guarantor Financial Information (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	$ 487,505	$ 415,591
Cost of services sold	273,068	221,573
Gross profit	214,437	194,018
Selling, general and administrative expenses	(189,020)	(159,877)
Goodwill and other long-lived asset impairment	0	(224,320)	[1]
Interest expense and other, net	(24,498)	(22,293)
Equity in earnings (loss) of subsidiaries	0	0
Income (loss) before income taxes	919	(212,472)
Income tax (expense) benefit	(421)	5,416
Net income (loss)	498	(207,056)
Less: Net income attributable to noncontrolling interests	(184)	(121)
Net income (loss) attributable to Gentiva shareholders	314	(207,177)
Comprehensive income (loss)	498	(207,056)
Gentiva Health Services, Inc. [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	0	0
Cost of services sold	0	0
Gross profit	0	0
Selling, general and administrative expenses	0	0
Goodwill and other long-lived asset impairment		0
Interest expense and other, net	(24,550)	(22,310)
Equity in earnings (loss) of subsidiaries	15,911	(193,791)
Income (loss) before income taxes	(8,639)	(216,101)
Income tax (expense) benefit	8,953	8,924
Net income (loss)	314	(207,177)
Less: Net income attributable to noncontrolling interests	0	0
Net income (loss) attributable to Gentiva shareholders	314	(207,177)
Comprehensive income (loss)	314	(207,177)
Guarantor Subsidiaries [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	474,694	403,144
Cost of services sold	266,093	213,202
Gross profit	208,601	189,942
Selling, general and administrative expenses	(183,887)	(155,249)
Goodwill and other long-lived asset impairment		(224,320)
Interest expense and other, net	0	0
Equity in earnings (loss) of subsidiaries	254	(397)
Income (loss) before income taxes	24,968	(190,024)
Income tax (expense) benefit	(9,057)	(3,767)
Net income (loss)	15,911	(193,791)
Less: Net income attributable to noncontrolling interests	0	0
Net income (loss) attributable to Gentiva shareholders	15,911	(193,791)
Comprehensive income (loss)	15,911	(193,791)
Non-Guarantor Subsidiaries [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	17,945	15,626
Cost of services sold	12,109	11,550
Gross profit	5,836	4,076
Selling, general and administrative expenses	(5,133)	(4,628)
Goodwill and other long-lived asset impairment		0
Interest expense and other, net	52	17
Equity in earnings (loss) of subsidiaries	0	0
Income (loss) before income taxes	755	(535)
Income tax (expense) benefit	(317)	259
Net income (loss)	438	(276)
Less: Net income attributable to noncontrolling interests	(184)	(121)
Net income (loss) attributable to Gentiva shareholders	254	(397)
Comprehensive income (loss)	438	(276)
Eliminations [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	(5,134)	(3,179)
Cost of services sold	(5,134)	(3,179)
Gross profit	0	0
Selling, general and administrative expenses	0	0
Goodwill and other long-lived asset impairment		0
Interest expense and other, net	0	0
Equity in earnings (loss) of subsidiaries	(16,165)	194,188
Income (loss) before income taxes	(16,165)	194,188
Income tax (expense) benefit	0	0
Net income (loss)	(16,165)	194,188
Less: Net income attributable to noncontrolling interests	0	0
Net income (loss) attributable to Gentiva shareholders	(16,165)	194,188
Comprehensive income (loss)	$ (16,165)	$ 194,188

[1] (2)At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit. Based on the results of the interim impairment test, the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million. See Note 9.In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million.Hospice and corporate assets were reduced by $220.8 million and $3.5 million , respectively, as a result of the impairment.